Improving Patient Care and Research Is Our Number One Concern

Regeneron Reports Positive Interim Data with REGEN-COV™ Antibody Cocktail used as Passive Vaccine to Prevent COVID-19

A very interesting update on one of our COVID-19 studies.

If you are interested in seeing if you qualify for this study, or any of our other studies, contact us today.

https://investor.regeneron.com/node/24791/pdf

Posted in

Triple O Research Institute

Leave a Comment





Categories

Subscribe!